Relation of thyroid hormones with the total and specific serum activity of N-acetyl-beta-D-glucosaminidase.
DOI:
https://doi.org/10.20344/amp.3484Abstract
Total serum N-acetyl-beta-D-glucosaminidase (NAG), isoenzyme A (labile) and isoenzyme B (stable) activities were determined in euthyroid controls and in thyroid disease. In twenty hyperthyroid individuals total NAG (856.9 +/- 122,676 nmols/h/ml and isoenzyme A (490.3 +/- 93.592) as well as isoenzyme B (361.6 +/- 66,371), were higher than the levels in nineteen hypothyroid [total NAG = 533.105 +/- 97.927 (p less than 0.001); isoenzyme A = 280.263 +/- 61.463 (p less than 0.001); isoenzyme B = 251,580 +/- 50,530 (p less than 0.001)] or in twenty euthyroid [total NAG = 555.55 +/- 75.59 (p less than 0.001); isoenzyme A = 316.85 +/- 55.0 (p less than 0.001); isoenzyme B = 238.95 +/- 39.60 (p less than 0.001)]. Monthly assays were performed in seven hypothyroid and eleven hyperthyroid over the course of their corrective treatment with L-thyroxine (LT4: 0.1-0.2 mg (day) and propylthiouracil (PTU: 0.3-0.4/day), respectively. Total T4 was taken as the criterion for thyroid status. The reduction of hormone activity in seven hyperthyroid was accompanied by a significant decrease in enzyme activity (NAG = p less than 0.02; isoenzyme A = p less than 0.02). Isoenzyme B displayed no significant variation. In four hyperthyroid submitted to treatment with PTU there was no reduction in NAG activity and although T4 came down to normal levels. These patients still displayed symptoms of hyperthyroidism.(ABSTRACT TRUNCATED AT 250 WORDS)Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.